Keystone Today

Rep. Brian Fitzpatrick, serving Pennsylvania’s 1st District, took to social media on April 8, 2025, to share his recent legislative endeavors and advocate for healthcare and research funding. Fitzpatrick, a member of the U.S. Congress since 2017, highlighted initiatives promoting green energy, biotechnology concerns, and healthcare cost solutions in a series of coordinated public messages.

On April 8, 2025, Fitzpatrick announced his involvement in advancing energy independence through legislative means. "American energy independence starts with smart, clean, homegrown solutions," Fitzpatrick declared, advocating for the Renewable Natural Gas Incentive Act of 2025. The initiative, developed collaboratively with other legislators, seeks to promote clean fuel alternatives.

Later that day, Fitzpatrick expressed concern regarding potential disruptions to active research funding. After engaging with the Pennsylvania Biotechnology Center, he voiced his worries to the National Institutes of Health (NIH) about potential research grant cancellations. He emphasized the significance of the Blumberg grant, writing, "After collaborating with the Pennsylvania Biotechnology Center in Doylestown, I immediately transmitted a communication to the NIH expressing serious concern about the potential cancellation of several active research grants—including the Blumberg grant, which supports vital work."

Following this, Fitzpatrick addressed healthcare affordability issues during a House Ways and Means Committee session. He reiterated his commitment to ensuring all Americans have access to essential medications. He stated, "Every American deserves access to affordable, life-saving medications—especially those battling cancer, chronic illnesses, and autoimmune diseases." His comments underscored his continued advocacy for lowering patient costs during the Health Subcommittee Hearing.